RxDoctor Payments Data

Jared Rosenberg, MD

Pain Medicine · Greenwich, CTNPI 1972985323

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,913 of the $12,454 with a category attached, or 63.5%. 13 manufacturers reported payments, led by Boston Scientific at 57.8% of the total. Among pain medicine clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,454in general payments, 2019–2025

Across 139 payments — averaging $89.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$7K
  • Medtronic$3K
  • SPR Therapeutics, Inc$602
  • Relievant Medsystems, Inc.$454
  • Nevro Corp.$448
  • MML US, Inc.$335
  • plus $658 from 7 others

What the payments were for

  • Grants$3,43028%
  • Travel & lodging$1,1129%
  • Food & beverage$7,91364%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,454 in reported general payments places this provider in the 90th percentile of 69 pain medicine providers in Connecticut.

See all pain medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$139,215
Medicare patients
268
Services billed
1,459

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl23$19,562
OxycontinOxycodone Hcl12$10,803
Xtampza ErOxycodone Myristate13$4,994
Oxycodone Hcl103$2,254
Gabapentin192$2,149
Diclofenac Sodium17$1,599
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$1,280
Lidocaine14$947
Celecoxib67$830
Naloxone Hcl12$773
Duloxetine Hcl43$698
Pregabalin42$668
Cyclobenzaprine Hcl52$435
Morphine Sulfate ErMorphine Sulfate13$252
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$217

Paid to pharmacies, not to this prescriber.

Other pain medicine in Greenwich

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →